Company / EPS (Basic)
ARS Pharmaceuticals, Inc. EPS (Basic) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$0.08
FY2025
5-year range
-$0.87 / $0.08
FY2021-FY2025
Trend
+114.0%
vs FY2024
Sector context
#47 of 208
Health Care
What the data says
ARS Pharmaceuticals, Inc.'s eps (basic) of $0.08 is higher than 77% of companies in the Health Care sector (FY2025). Improved from $-0.87 to $0.08 over the past 2 years.
Based on SEC 10-K filings.
0.08 in FY2025. Top quartile in the Health Care sector.
Improved from $-0.87 to $0.08 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 208This company $0.08 Sector average -$0.87
▼
+109.2% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 114.0% year-over-year.
- Ranks #47 out of 208 companies in the Health Care sector.
- Lowest eps (basic) in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.08 | +114.0% |
| FY2024 | -$0.57 | +34.5% |
| FY2023 | -$0.87 | -24.3% |
| FY2022 | -$0.70 | +0.0% |
| FY2021 | -$0.70 | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026